Jaime Vieser, Director at Ziopharm Oncology (NASDAQ:ZIOP), made a large insider buy on September 29, according to a new SEC filing.

What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Vieser purchased 100,000 shares of Ziopharm Oncology at at a price of $1.91. The total transaction amounted to $191,000.

Following the transaction, Vieser now owns 780,321 shares of the company, worth $1,468,954.

Ziopharm Oncology shares are trading up 5.76% at $1.88 at the time of this writing on Tuesday morning.

Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.

The Importance of Insider Transactions

Insider transactions shouldn't be used primarily to make an investing decision, however an insider transaction can be an important factor in the investing decision.

In legal terms, an "insider" refers to any shareholder who owns at least 10% of a company. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.

When a company insider makes a new purchase, that is an indication that they expect the stock to rise.

Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down.

Transaction Codes To Focus On

Investors prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates the insider may have been forced to sell shares in order to receive compensation that had been promised upon being hired by the company.

Check Out The Full List Of Ziopharm Oncology's Insider Trades.

See more from Benzinga

• Click here for options trades from Benzinga
• 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
• 12 Health Care Stocks Moving In Tuesday's Intraday Session

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.